Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9289 - 9296 of 12089 results
FCC Ruling Addresses Robocalls by Health Care Providers
July 27, 2015| Blog| Viewpoint
"3-Year" DACA EADs Must Be Returned
July 24, 2015| Blog| Viewpoint
Filing EB-5 exemplar petitions before September 30, 2015: strategic considerations
July 24, 2015| Blog| Viewpoint
Australia - A New Frontier for Plaintiffs?
July 23, 2015| Blog| Viewpoint
New York Becomes First State to Raise Minimum Wage to $15 ... For Fast Food Workers
July 23, 2015| Blog| Viewpoint
Immigration-Related Documents and Information Not Discoverable in Wage and Hour Lawsuit
July 23, 2015| Blog| Viewpoint
EU Court Clarifies the Conditions Under Which Assertion of Standard-Essential Patents May Constitute Abuse of Market Dominance
July 23, 2015| Alert| Viewpoint
Class Action Suit Filed Against UCLA After It Suffers Massive Data Breach Affecting 4.5 Million Individuals
July 23, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|